Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
AQP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C10orf88 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM162A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLAMF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP8B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FRAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPCS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MVK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDOC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7110 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAND2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC61A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on